Financhill
Back

Arcturus Therapeutics Holdings Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
38

ARCT
Arcturus Therapeutics Holdings

Last Price:
18.25
Seasonality Move:
9.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Arcturus Therapeutics Holdings Stock Forecast

  • Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 27.6% based on the past 11 years of stock performance.
  • Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
  • Is Arcturus Therapeutics Holdings Stock Undervalued?
    The current Arcturus Therapeutics Holdings [ARCT] share price is $18.33. The Score for ARCT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Arcturus Therapeutics Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 27.6% based on the past 11 years of stock performance.

Arcturus Therapeutics Holdings Stock Rating

Sell
38
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings overpriced?

  • Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%

Arcturus Therapeutics Holdings Stock Price History

Is ARCT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com

52-Week Data

52-Week High:
45.00
52-Week Low:
17.26

Prediction Charts

Market Cap:
495.68M
Price in USD:
18.33
Volume:
777.9K
Beta:
2.54

Technical Analysis

SMA50:
20.68
SMA100:
21.75
SMA200:
27.62
52-Wk Change:
-0.49%

Stock Predictions

  • Is Arcturus Therapeutics Holdings stock public?
    Yes, Arcturus Therapeutics Holdings is a publicly traded company.
  • What is the Arcturus Therapeutics Holdings stock quote today?
    The Arcturus Therapeutics Holdings stock price is 18.33 USD today.
  • How to buy Arcturus Therapeutics Holdings stock online?
    You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-18 20.78 21.15 21.17 20.47
Oct-21 20.98 20.88 21.20 20.44
Oct-22 20.69 19.79 20.71 19.67
Oct-23 19.71 20.00 20.36 19.35
Oct-24 20.10 19.00 20.10 18.67
Oct-25 19.04 18.95 19.57 18.62
Oct-28 19.09 19.57 20.13 18.78
Oct-29 19.26 19.12 19.36 18.91
Oct-30 18.88 18.42 19.01 18.14
Oct-31 18.31 17.73 18.35 17.66
Nov-1 18.09 18.00 18.36 17.50
Nov-4 18.16 17.82 18.30 17.53
Nov-5 17.71 18.35 18.40 17.26
Nov-6 19.14 18.33 19.30 17.73

Arcturus Therapeutics Holdings Earnings

Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Arcturus Therapeutics Holdings Forecast Revenue Growth

Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.

* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.